Lookup NU author(s): Professor Hamish McAllister-Williams
This is the authors' accepted manuscript of an article that has been published in its final definitive form by Mark Allen Group, 2019.
For re-use rights please refer to the publisher's terms and conditions.
The use of psychotropic medication in pregnant and breastfeeding women is an area of great challenge for both women with mental health problems and clinicians. There are many uncertainties regarding risks of untreated illness to mother, fetus or infant as well as concerns over potential risks to the fetus or infant associated with use of psychotropic medications during pregnancy or breastfeeding. The purpose of the British Association of Psychopharmacology guidelines is to provide advice regarding making decisions around treating mental illness in the perinatal period. This article provides a summary and explanation of the consensus guidance.
Author(s): Romaine E, McAllister-Williams RH
Publication type: Article
Publication status: Published
Journal: British Journal of Hospital Medicine
Online publication date: 28/12/2018
Acceptance date: 02/04/2018
Date deposited: 27/02/2019
ISSN (print): 1750-8460
ISSN (electronic): 1759-7390
Publisher: Mark Allen Group
PubMed id: 30592677
Altmetrics provided by Altmetric